News Articles Tagged: CRC Treatment
Fruquintinib: A Targeted Therapy for Advanced Colorectal Cancer Patients
Discover how Fruquintinib's targeted approach and clinical trial successes offer new hope for patients with previously treated advanced colorectal cancer.
Navigating Fruquintinib Treatment: Efficacy, Safety, and Patient Journey Insights
NINGBO INNO PHARMCHEM CO.,LTD. shares insights into the patient journey with Fruquintinib, covering its efficacy, safety profile, and practical considerations for managing this advanced CRC therapy.
NINGBO INNO PHARMCHEM CO.,LTD.: Leading the Way in Targeted Colorectal Cancer Therapies with SN38-Glucose Conjugates
NINGBO INNO PHARMCHEM CO.,LTD. is innovating targeted colorectal cancer therapies with SN38-glucose conjugates, enhancing drug delivery and efficacy by targeting cancer cell metabolism.